-
The global digital analog display of air pollution erosion is shocking!
Time of Update: 2021-07-28
According to the Daily Mail website, two French scientists living in Beijing used data from more than 8,000 atmospheric monitoring points around the world to create a real-time model of the earth’s atmospheric pollution .
-
Staying up late will "be stupid". During sleep, the brain will start a "detoxification" program to clear the brain...
Time of Update: 2021-06-23
Recently, researchers from the University of Pennsylvania published an article titled Reduced coupling between cerebrospinal fluid flow and global brain activity is linked to Alzheimer disease-related pathology in PLOS Biology.
-
Oncology NGS industry opens second curve, MRD recurrence monitoring leads industry changes
Time of Update: 2021-06-23
Starting from the second half of 2020, tumor recurrence monitoring based on MRD (Residual Minimal Lesion) has become an "invisible" hot spot in the industry.
As an application scenario juxtaposed with early screening and companion diagnosis, the status of recurrence monitoring in the oncology NGS industry has not received enough attention .
-
Eli Lilly's oral JAK inhibitor Olumiant effectively improves pain/body function...
Time of Update: 2021-06-23
Olumiant is a tyrosine protein kinase (JAK) 1/2 inhibitor, administered orally once a day, suitable for moderate to severe patients with poor efficacy or intolerance to one or more disease-improving anti-rheumatic drugs (DMARD) Adult patients with active rheumatoid arthritis can be used in combination with methotrexate or other non-biological anti-rheumatic drugs .
-
US FDA approves Tembexa: the first smallpox for all ages...
Time of Update: 2021-06-23
Chimerix recently announced that the US Food and Drug Administration (FDA) has approved Tembexa (brincidofovir) tablets and oral suspensions for the treatment of smallpox .
Chimerix Receives US Food and Drug Administration approval for TEMBEXA® (brincidofovir) for the Treatment of Smallpox
-
FDA Regarding the Disposal of Johnson & Johnson's Covid-19 Vaccine Stock Produced in Emergent...
Time of Update: 2021-06-22
After performing additional tests, Janssen confirmed the OOS test results and subsequently notified Emergent about the cross-contamination of DS GMP8 with the AZ adenovirus vector vaccine produced in other areas of the EMOB plant .
-
Biogen brings the gospel to Alzheimer's disease for the first time since 2003...
Time of Update: 2021-06-20
According to the terms of accelerated approval, the FDA requires Biogen to conduct a new randomized controlled clinical trial to verify the clinical efficacy of the drug .
-
Xinrui α-Radiation Cancer Therapy Receives FDA Breakthrough Medical Device Certification
Time of Update: 2021-06-20
Alpha Tau submitted data to the US FDA to support this determination, including preliminary clinical studies of Alpha DaRT in the treatment of skin, head and neck SCC, in which almost 80% of the lesions showed complete remission, and 100% showed partial or complete remission.
-
How do the potential "culprits" of various neurological diseases damage the brain?
Time of Update: 2021-06-20
Scientists examined the brains of patients with Alzheimer's disease after death, and found evidence of splicing-related defects in the cells, that is, spliceosome components tangled with tau protein aggregates were found in the cells .
-
Financing continues to explode, and Internet medical companies such as Kuaiyao are "healthy...
Time of Update: 2021-06-20
In 2014, Renhe Pharmaceuticals invested 5 million yuan in angel rounds to establish Dingdang Kuaiyao, starting with O2O drug delivery business .
The financial report shows that Ping An Good Doctor still has a huge loss of 949 million yuan in fiscal 2020 .
-
2020 Medical Insurance Statistics Bulletin released!
Time of Update: 2021-06-20
The hospitalization expenses fund payment within the policy scope of secondary and lower-level medical institutions was 87.
The hospitalization expenses fund payment within the policy scope of secondary and lower-level medical institutions was 87.
-
The industry proposes to write a new USP chapter for visual inspection to achieve standardization and consistency of visual inspection
Time of Update: 2021-06-20
They suggested the development of a harmonized pharmacopoeia chapter, which includes the use of a "universal standard set" to train visual inspectors, confirm methods, and verify results .
-
Policy·Resolve the introduction of human growth hormone into the inter-provincial collection of national medicines to open the "dual channel"...
Time of Update: 2021-06-12
With the continuous expansion of the scope of the centralized procurement of pharmaceuticals in my country and the continuous strengthening of policy, the impact on the medical and pharmaceutical industry is also deepening.
Previously, medical insurance negotiations had strict procedures for drugs to enter the hospital.
-
How to coordinate the interests of the four parties in the "three-medicine linkage"?
Time of Update: 2021-06-06
In the "Implementation Opinions on Promoting the Reform of the Medical Security Fund Supervision System" issued by the General Office of the Provincial Government, Hebei has classified and refined the policies for the return of medical insurance fund balance rewards, and clarified the implementation of centralized procurement of drugs and medical consumables.
-
10 Chinese products are shortlisted in the British Ministry of Health's new crown antigen reagent list
Time of Update: 2021-06-06
A few days ago, the British Ministry of Health website has updated the "List of Validated New Coronary Antigen Kit Products".
The updated list shows that 24 new coronavirus antigen reagents have passed the verification, 10 of which are manufactured by Chinese companies, including Oriental Bio, Deep Blue Medical, Products from Delanos, Shuoshi Biology, Aikang Biology, Jidan Biology, etc.
-
Geologists "cross-border" reveal the structure of kidney stones and propose new methods for prevention and treatment
Time of Update: 2021-06-06
▲The continuous crystalline layer formed in human kidney stones is very similar to the agate in natural volcanic rock sediments (picture source: reference [2]; Credit: Mayandi Sivaguru)
-
Looking at the achievements and future development of the National Smart Medical Insurance Laboratory from a multi-dimensional perspective
Time of Update: 2021-06-03
The laboratory always adheres to the responsibility of "serving the overall situation in one domain", and better supports and serves the responsibility of the efficient construction of national medical insurance informatization, closely following the dual function positioning of "information center and experimental environment", and mainly undertakes medical insurance informatization test verification, operation and maintenance Services, smart medical insurance innovation management, etc.
-
Innovative therapy to effectively improve cognitive impairment was recognized as a breakthrough therapy by the FDA
Time of Update: 2021-06-03
[1] Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation.
[1] Boehringer Ingelheim's Investigational Treatment for Cognitive Impairment Associated with Schizophrenia Receives FDA Breakthrough Therapy Designation.
-
Quantitative and QMM--an alternative method to accelerate drug development
Time of Update: 2021-06-03
It is important to find new ways to develop and speed up the process, and one of the solutions that have gained widespread attention in the past few years involves quantitative methods and modeling (QMM), which cover a variety of methods that can be commonly used in the modernization of generic drugs.
-
Bristol-Myers Squibb partners with Xencor to extend COVID-19 antibody half...
Time of Update: 2021-06-03
Bristol Myers Squibb will use Xencor's technology to extend the half-life of SARS-CoV-2 neutralizing monoclonal antibody combination therapy.
2. Bristol Myers Squibb: Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend™ XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
